Search

everythinglearnresearchcommunity

for

Search:↓

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Transgender treatment includes hormones and surgery, but long-term effects are unknown and counseling is needed.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Dermatologists are important in helping transgender people with skin issues and physical changes during their transition.

Testosterone treatment in transgender teens can worsen acne, requiring careful treatment due to mental health and medication side effects.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Forehead reduction and orbital contouring are important for satisfactory facial feminization in transgender females, with high satisfaction and low long-term problems.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Transgender women can still get testicular cancer, so proper screening is important.

Hair transplantation can help transgender patients affirm their gender identity.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Testosterone increases hair growth and acne in transgender men.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Transgender women on estrogen therapy can develop melasma and need proper skin care.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Spironolactone and finasteride are equally effective for hirsutism in transgender women.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Many transgender men on testosterone therapy experience hair loss.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Transgender and gender diverse youth often have skin issues like acne and scarring, but few get referred to dermatologists.